NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $0 | – | 4 | +33.3% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 3 | -98.5% | 0.00% | -100.0% |
Q4 2020 | $35,000 | +250.0% | 200 | +63.9% | 0.00% | +200.0% |
Q4 2019 | $10,000 | -93.2% | 122 | -93.8% | 0.00% | -93.8% |
Q3 2019 | $146,000 | +2333.3% | 1,961 | +1861.0% | 0.02% | +1500.0% |
Q2 2019 | $6,000 | +20.0% | 100 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $5,000 | +66.7% | 100 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $3,000 | -40.0% | 100 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $5,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |